Safehouse, the nonprofit behind Philadelphia’s proposed supervised injection facility, is waiting on a federal judge to determine whether it’s legal to open the first medical site of its kind in the U ...
The Food and Drug Administration on Wednesday approved Gilead's twice-yearly antiviral injection for preventing HIV — a milestone that the company and some experts say could help bring the world ...
Gilead Sciences, maker of the drug, announced that a twice-a-year injection of lenacapavir has been approved in the United States for HIV prevention under the brand name Yeztugo, and seen here in New ...
Safehouse, the nonprofit behind Philadelphia’s proposed supervised injection facility, is waiting on a federal judge to determine whether it’s legal to open the first medical site of its kind in the U ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results